Amantadine penetration into cerebrospinal fluid of a child with influenza A encephalitis

Pediatric Infectious Disease Journal

Volumn 23, Issue 3, 2004, Pages 270-272

  Geskey, Joseph M ^a   Thomas, Neal J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Amantadine; Cerebrospinal fluid; Encephalitis; Influenza A; Pediatric

Indexed keywords

AMANTADINE;

ARTICLE; BRAIN DYSFUNCTION; CASE REPORT; CEREBROSPINAL FLUID; CHILD; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; FEMALE; HUMAN; INFLUENZA VIRUS A; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS ENCEPHALITIS;

ACUTE DISEASE; AMANTADINE; ANTIVIRAL AGENTS; CEREBROSPINAL FLUID; ENCEPHALITIS, VIRAL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA, HUMAN;

EID: 1542514014     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000115647.66193.45     Document Type: Article

References (13)

1. Morishima T, Togashi T, Yokota S, et al. and the Collaborative Study Group on Influenza-associated Encephalopathy in Japan. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002;35:512-17.
2. Sugaya N. Influenza-associated encephalopathy in Japan: pathogenesis and treatment. Pediatr Int 2000;42:215-8.
3. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003;22:164-77.
4. Sugaya N, Miura M. Amantadine therapy for influenza type-A-associated encephalopathy. Pediatr Infect Dis J 1999;18:734.
5. Munakata M, Kato R, Yokoyama H, et al. Combined therapy with hypothermia and anticytokine agents in influenza A encephalopathy. Brain Dev 2000;22:373-7.
6. Straumanis JP, Tapia MD. Influenza B infection associated with encephalitis: treatment with oseltamivir. Pediatr Infect Dis J 2002;21:173-5.
7. Fujimoto S. Kobayahi M, Uemura O, et al. PCR on cerebrospinal fluid to show influenza-associated encephalopathy or encephalitis. Lancet 1998;352:873-5.
8. McCall S, Henry JM, Reid AH, et al. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol 2001;60:696-704.
9. Ito Y, Ichiyama T, Kimura H, et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol 199;58:420-5.
10. Tominack RL, Hayden FG. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am 1987;1:459-78.
11. Kornhuber J, Quack G, Danysz K, et al. Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology 1995;34:713-21.
12. Vernier VG, Harmon JB, Stump JM, et al. The toxicology and pharmacologic properties of amantadine hydrochloride. Toxicol Appl Pharmacol 1969;15:642-65.
13. Takahashi M, Yamada T, Nakashita Y, et al. Influenza virus-induced encephalopathy: clinicopathologic study of an autopsied case. Pediatr Int 2000;42:204-14.